Studying the impact of a medication use evaluation for polymedicated older patients by the community pharmacist (SIMENON): study protocol

J Wuyts, J Maesschalck, I De Wulf, K Foubert, K Boussery, J De Lepeleire, V Foulon, J Wuyts, J Maesschalck, I De Wulf, K Foubert, K Boussery, J De Lepeleire, V Foulon

Abstract

Background: Aged polymedicated patients are particularly vulnerable for drug-related problems. A medication review aims to optimize the medication use of patients and improve health outcomes. In this study, the effect of a pharmacist-led medication use review is investigated for polymedicated ambulatory older patients with the aim of implementing this pharmaceutical care intervention across Belgium.

Methods: This article describes the study protocol of the SIMENON study and reports the results of the feasibility study, which aimed to test and optimize this study protocol. In the SIMENON intervention study, 75 Belgian community pharmacies each recruit 12 patients for a medication use review. For each patient, the identified drug-related problems and subsequent interventions are registered using the PharmDISC classification. In a subset of Dutch speaking patients, a pretest-posttest single group design is used to measure the impact of this review on patient related outcomes using questionnaires. The main outcome of the study is the type and number of drug-related problems and related interventions. A second outcome is the impact of the medication use review on adherence, objectively measured with dispensing data. Evolution in medication related quality of life is another outcome, measured with the Living with Medicines Questionnaire version 3. Other patient reported outcomes include adherence, self-management, patient satisfaction, fall incidents and use of emergency healthcare services.

Discussion: The findings of this study can provide data on the effectiveness of a medication use review in the Belgian primary care setting. Furthermore, it will provide insights in which patients benefit most of this intervention and therefore facilitate the implementation of medication review in Belgium.

Trial registration: ClinicalTrials.gov NCT03179722 . Retrospectively registered 7 June 2017.

Keywords: Aged; Community pharmacist; Drug-related problems; Medication review; Medication use.

Conflict of interest statement

This study protocol has been approved by the ethics committee UZ/KU Leuven (number S59676 V3) in November 2016. All participating pharmacies signed a study contract and all patients gave a written informed consent for study participation to their community pharmacist.

Not applicable.

The authors declare that they have no competing interests.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Belgisch Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV) Polyfarmacie bij ouderen. 2014.
    1. Maher RL, Hanlon JT, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:1–11. doi: 10.1517/14740338.2013.827660.
    1. Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890–1896.
    1. Beijer HJM, De Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24:46–54. doi: 10.1023/A:1015570104121.
    1. IMS Institute for Healthcare Informatics . IMS Health Report: Advancing the responsible use of medicines - Applying levers for change. 2015.
    1. Pharmaceutical Care Network Europe . Position paper on the PCNE definition of medication review. 2016.
    1. Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2013;77:102–115. doi: 10.1111/bcp.12140.
    1. Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality (review) Cochrane Database Syst Rev. 2013;2:CD008986.
    1. Riordan DO, Walsh KA, Galvin R, Sinnott C, Kearney PM, Byrne S. The effect of pharmacist-led interventions in optimising prescribing in older adults in primary care: a systematic review. SAGE Open Med. 2016;4:1–18. doi: 10.1177/2050312116652568.
    1. Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2007;65:303–316. doi: 10.1111/j.1365-2125.2007.03071.x.
    1. Bulajeva A, Labberton L, Leikola S, Pohjanoksa-Mäntylä M, Geurts M, de Gier J, et al. Medication review practices in European countries. Res Soc Adm Pharm. 2014;10:731–740. doi: 10.1016/j.sapharm.2014.02.005.
    1. Anrys P, Strauven G, Boland B, Dalleur O, Declercq A, Degryse J-M, et al. Collaborative approach to optimise MEdication use for older people in nursing homes (COME-ON): study protocol of a cluster controlled trial. Implement Sci. 2016;11:35. doi: 10.1186/s13012-016-0394-6.
    1. Tommelein E, Petrovic M, Somers A, Mehuys E, Van Der Cammen T, Boussery K. Older patients’ prescriptions screening in the community pharmacy: development of the Ghent older People’s prescriptions community pharmacy screening (GheOP3S) tool. Aust J Public Health. 2016;38:e158–e170. doi: 10.1093/pubmed/fdv090.
    1. Glasgow R, Vogt T, Boles S. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89:1322–1327. doi: 10.2105/AJPH.89.9.1322.
    1. Chan A, Tetzlaff J, Altman D, Laupacis A, Gøtzsche P, Krleža-Jerić K, et al. Research and reporting methods annals of internal medicine SPIRIT 2013 Statement : defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–207. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Tommelein E, Mehuys E, Van Tongelen I, Petrovic M, Somers A, Colin P, et al. Community pharmacists’ evaluation of potentially inappropriate prescribing in older community-dwelling patients with polypharmacy: observational research based on the GheOP3S tool. J Public Health. 2016;39(3):1–10.
    1. Keijsers CJPW, Van Doorn ABD, Van Kalles A, De Wildt DJ, Brouwers JRBJ, Van De Kamp HJ, et al. Structured pharmaceutical analysis of the systematic tool to reduce inappropriate prescribing is an effective method for final-year medical students to improve polypharmacy skills: a randomized controlled trial. J Am Geriatr Soc. 2014;62:1353–1359. doi: 10.1111/jgs.12884.
    1. Maes KA, Bruch S, Hersberger KE, Lampert ML. Documentation of pharmaceutical care: development of an intervention oriented classification system. Int J Clin Pharm. 2017;39:354–363. doi: 10.1007/s11096-017-0442-6.
    1. Krska J, Katusiime B, Corlett S. Validation of an instrument to measure patients’ experiences of medicine use: the living with medicines questionnaire. Patient Prefer Adherence. 2017;11:671–679. doi: 10.2147/PPA.S126647.
    1. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Heal. 2005;8:95–104.
    1. Kleppe M, Lacroix J, Ham J, Midden C. The development of the ProMAS: a probabilistic medication adherence scale. Patient Prefer Adherence. 2015;9:355–367. doi: 10.2147/PPA.S76749.
    1. Messerli M, Blozik E, Vriends N, Hersberger KE. Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial. BMC Health Serv Res. 2016;16:145. doi: 10.1186/s12913-016-1384-8.
    1. National institute for Health and Care Excellence (NICE) Medicines Optimisation: The safe and effective use of medicines to enable the best possible outcomes. 2015.
    1. Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP). Richtlijn medicatiebeoordeling. 2013; . Accessed 1 Oct 2016.
    1. Loh Z, Cheen M, Wee H. Humanistic and economic outcomes of pharmacist-provided medication reviews in the elderly: a systematic review and meta-analysis. J Clin Pharm Ther. 2016;41:621–633. doi: 10.1111/jcpt.12453.
    1. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005;330:293–0.
    1. Krska J, Morecroft CW, Rowe PH, Poole H. Measuring the impact of long-term medicines use from the patient perspective. Int J Clin Pharm. 2014;36:675–678. doi: 10.1007/s11096-014-9970-5.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel